Ultrasound Stimulation for Arthritis
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if ultrasound treatment can reduce inflammation in individuals with types of arthritis such as Rheumatoid Arthritis, Psoriatic Arthritis, or Axial Spondyloarthritis. Participants will undergo ultrasound sessions, with some receiving real Ultrasound Stimulation and others receiving a sham (fake) treatment for comparison. The trial focuses on tracking changes in inflammation markers in the blood. This study may suit individuals who have had one of these arthritis conditions for at least six months and are on a stable medication regimen. As an unphased trial, it offers a unique opportunity to contribute to innovative research that could lead to new treatment options for arthritis.
Will I have to stop taking my current medications?
Participants with Inflammatory Arthritis can continue their current stable dose of immunomodulatory medications while in the study. However, if you have recently started or changed certain medications like JAK inhibitors, DMARDs, or corticosteroids, you may not be eligible to participate.
What prior data suggests that this ultrasound stimulation is safe for people with inflammatory arthritis?
Research shows that ultrasound treatments are generally safe. A 2012 review examined various uses of therapeutic ultrasound and found it well-tolerated with few side effects. Another study discovered that focused low-intensity pulsed ultrasound effectively reduces pain and improves movement in people with knee osteoarthritis.
Furthermore, research from Sunnybrook Health Sciences Centre demonstrated that focused ultrasound is safe and effective for treating symptoms of certain conditions. This suggests that ultrasound therapy could be a useful tool for managing pain in muscle and bone issues. Overall, these studies support the safety of ultrasound treatments, although individual experiences may differ.12345Why are researchers excited about this trial?
Unlike traditional treatments for arthritis that often rely on medications like NSAIDs or corticosteroids to reduce inflammation and pain, ultrasound stimulation offers a non-invasive and drug-free approach. This method uses sound waves to potentially reduce pain and improve joint function without the side effects associated with long-term medication use. Researchers are excited about ultrasound stimulation because it could provide a quicker and safer way to manage arthritis symptoms, making it an appealing option for those looking for alternative treatments.
What evidence suggests that ultrasound stimulation is effective for inflammatory arthritis?
Research has shown that ultrasound can help with arthritis by reducing pain and improving movement. In this trial, participants will receive either active ultrasound stimulation or non-active ultrasound stimulation (sham) during their visits. One study demonstrated that ultrasound treatment safely eased pain and improved mobility in people with knee arthritis. Another study found that low-intensity pulsed ultrasound improved blood flow and aided tissue healing. These studies suggest that ultrasound might effectively manage arthritis symptoms by reducing swelling and aiding tissue repair.26789
Are You a Good Fit for This Trial?
This trial is for healthy individuals and those with various forms of inflammatory arthritis, such as rheumatoid arthritis and ankylosing spondylitis. Participants should be willing to undergo ultrasound stimulation sessions.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 5 ultrasound sessions, with 3 active and 2 sham treatments, to assess anti-inflammatory response
Follow-up
Participants are monitored for changes in pro-inflammatory cytokines at 2 hours and 24 hours post-therapy
What Are the Treatments Tested in This Trial?
Interventions
- Non-active ultrasound stimulation
- Ultrasound Stimulation
Ultrasound Stimulation is already approved in European Union for the following indications:
- Back pain secondary to facet joint arthritis
Find a Clinic Near You
Who Is Running the Clinical Trial?
Surf Therapeutics
Lead Sponsor